Application of polymerase chain reaction-based restriction fragment length polymorphism in typing ocular rapid-growing nontuberculous mycobacterial isolates from three patients with postoperative endophthalmitis

Cornea

Volumn 26, Issue 6, 2007, Pages 729-735

  Palani, Deepa ^a   Kulandai, Lily Therese ^a   Naraharirao, Madhavan Hajib ^a   Guruswami, Sitalakshmi ^a   Ramendra, Bakshi ^a  

^a VISION RESEARCH FOUNDATION   (India)

Author keywords

Mycobacterium abscessus; Mycobacterium fortuitum sorbitol positive third biovariant; Polymerase chain reaction based restriction fragment length polymorphism; Postoperative endophthalmitis; Rapid growing nontuberculous mycobacteria

Indexed keywords

HEAT SHOCK PROTEIN 65;

ACID FAST BACTERIUM; ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOCHEMISTRY; CASE REPORT; CATARACT EXTRACTION; CELL CULTURE; CORNEA; ENDOPHTHALMITIS; EVISCERATION; FEMALE; HUMAN; HUMAN TISSUE; LENS IMPLANTATION; MALE; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM FORTUITUM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN TARGETING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMEAR;

AGED; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CATARACT EXTRACTION; CHAPERONINS; CORNEA; DNA PRIMERS; DNA, BACTERIAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POSTOPERATIVE COMPLICATIONS;

EID: 34447502209     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318060ac3a     Document Type: Article

References (47)

1. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. The official statement of the American thoracic Society. Am J Respir Crit Care Med. 1997;156:S1-S25.
2. Wallace RJ Jr, Brown BA, Only GO. Skin, soft tissue and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992;166:405-412.
3. Patel R, Roberts GD, Keating MR, et al. Infection due to nontuberculous mycobacteria in kidney, heart and liver transplant recipients. Clin Infect Dis. 1994;19:263-273.
4. Ara M, de Santamaria CS, Zaballos P, et al. Mycobacterium chelonae infection with multiple cutaneous lesions after treatment with acupuncture. Int J Dermatol. 2003;42:642-644.
5. Behroozan DS, Christian MM, Moy RL. Mycobacterium fortuitum infection following neck liposuction: a case report. Dermatol Surg. 2000;26:588-590.
6. Meyers H, Brown-Elliott BA, Moore D, et al. An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis. 2002;34:1500-1507.
7. Murillo J, Torres M, Bofill L, et al. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. Arch Dermatol. 2000;136:1347-1352.
8. Fox LP, Geyer AS, Husain S, et al. Mycobacterium abscessus cellulitis and multifocus abscesses of the breasts in a transsexual from illicit intramammary injections of silicone. J Am Acad Dermatol. 2004;50:450-454.
9. Haiavy J, Tobin H.Mycobacterium fortuitum breast implants infection in prosthetic breast implants. Plast Reconstr Surg. 2002;109:2124-2128.
10. Heistein JB, Mangino JE, Ruberg RL, et al. A prosthetic breast implant infected with Mycobacterium fortuitum. Ann Plast Surg. 2000;44:330-333.
11. Katz VL, Farmer R, York J, et al. Mycobacterium chelonae sepsis associated with long-term use of an intravenous catheter for treatment of hyperemesis gravidarum: a case report. J Reprod Med. 2000;45:581-584.
12. 2 laser. Dermatol Surg. 2002;28:768-771.
13. Saluja A, Peters NT, Lowe L, et al. A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Dermatol Surg. 1997;23:539-543.
14. Sniezek PJ, Graham BS, Busch HB, et al. Rapidly growing mycobacterial infections after pedicures. Arch Dermatol. 2003;139:629-634.
15. Winthrop KL, Abrams M, Yakrus M, et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med. 2002;346:1366-1371.
16. Winthrop KL, Albridge K, South D, et al. The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection. Clin Infect Dis. 2004;38:38-44.
17. Alfa MJ, Sisler JJ, Harding GK.Mycobacterium abscessus infection of a Norplant contraceptive implant site. CMAJ. 1995;153:1293-1296.
18. Sharma S, Tleyjeh IM, Espinosa RE, et al. Pacemaker infection due to Mycobacterium fortuitum. Scand J Infect Dis. 2005;37:66-67.
19. Torres JR, Rios-Fabra A, Montecinos E, et al. Injection site abscess due to the Mycobacterium fortuitum-chelonae complex in the immunocompetent host. Infect Dis Clin Pract. 1998;7:56-60.
20. Villanueva A, Vargas BA, Ruiz F, et al. Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis. 1997;24:1147-1153.
21. Centers for Disease Control and Prevention. Infection with Mycobacterium abscessus associated with intramuscular injection of adrenal cortex extract-Colorado and Wyoming, 1995-1996. MMWR Morb Mortal Wkly Rep. 1996;45:713-715.
22. Ford JG, Huang AJW, Plugfelder SC, et al. Nontuberculous mycobacterial keratitis in South Florida. Ophthalmology. 1998;105:1652-1658.
23. Garg P, Bansal AK, Sharma S, et al. Bilateral infectious keratitis after laser in situ keratomileusis. Ophthalmology. 2001;108:121-125.
24. Smiddy WE, Miller D, Flynn HW Jr. Scleral buckle infections due to atypical mycobacteria. Retina. 1991;11:394-398.
25. Sudesh S, Cohen E, Schwartz LW, et al. Mycobacterium chelonae infection in a corneal graft. Arch Ophthalmol. 2000;118:294-295.
26. Lalitha P, Rathinam SR, Srinivasan M. Ocular infections due to nontuberculous mycobacteria. Indian J Med Microbiol. 2004;22:231-237.
27. Ramaswamy AA, Biswas J, Bhaskar V, et al. Post operative Mycobacterium chelonae endophthalmitis after extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmology. 2000;107:1283-1286.
28. Mutyala S, Dieckert JP, Papasian CJ. Mycobacterium fortuitum endophthalmitis. Retina. 1996;16:122-124.
29. Marin-Casanova P, Amiguetti JLC, Garcio-Martos P, et al. Endophthalmitis caused by Mycobacterium abscessus. Eur J Ophthalmol. 2003;13:800-802.
30. Alvarenga L, Freitas D, Hofling-Lima AL, et al. Infectious post-LASIK crystalline keratopathy caused by nontuberculous mycobacteria. Cornea. 2002;21:426-429.
31. Scott IU, Lieb DF, Flynn HW Jr, et al. Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcome of treatment. Arch Ophthalmol. 2003;121:573-576.
32. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new Mycobacteria of the 1990s. Clin Microbiol Rev. 2003;16:319-354.
33. Schinsky MF, Morey RE, Steigerwalt AG, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol. 2004;54:1653-1667.
34. Wallace RJ, Brown-Elliott BA, Wilson RW, et al. Clinical and laboratory features of Mycobacterium porcinum. J Clin Microbiol. 2004;42:5689-5697.
35. Management of opportunist mycobacterial infections: joint tuberculosis committee guidelines 1999. Subcommittee of the Joint tuberculosis Committee of the British Thoracic Society. Thorax. 2000;55:210-218.
36. Watt B, Rayner A, Harris G. Mycobacterium. In: Collee JG, Fraser AG, Marmion BP, Simmons A, eds. Practical Medical Microbiology, 4th ed. New York: Churchill Livingstone; 1996:334-335.
37. Vacher S, Pellegrin JL, Leblanc F, et al. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin. J Antimicrob Chemother. 1999;44:647-652.
38. Diane MC, Martha AC, Lynne SG, et al. Mycobacteria. In: Betty AF, Daniel FS, Alice SW, eds. Bailey and Scott's, Diagnostic Microbiology. 9th ed. St. Louis, MO: Mosby Publications; 1990:590-633.
39. Lennette EH, Balows A, Hanslea WJ Jr, et al. Manual of Clinical Microbiology. Washington, DC: ASM Publications; 1985.
40. Telenti A, Marchesi F, Balz M, et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction analysis. J Clin Microbiol. 1993;31:175-178.
41. McNabb A, Eisler D, Adie K, et al. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of mycobacterium species isolated from clinical sources. J Clin Microbiol. 2004;42:3000-3011.
42. Konig B, Tammer I, Sollich V, et al. Intra and inter patient variability of the hsp 65 and 16S-23 S intergenic region in Mycobacterium abscessus strains from patients with cystic fibrosis. J Clin Microbiol. 2005;43:3500-3503.
43. Steingrube VA, Gibson JL, Brown BA, et al. PCR amplification and restriction endonuclease analysis of a 65- kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol. 1995;33:149-153.
44. Grenzebach UH, Busse H, Totsch M, et al. Endophthalmitis induced by atypical mycobacterial infection. Ger J Ophthalmol. 1996;5:202-206.
45. Plikaytis BEB, Plikaytis BD, Yakrus MA, et al. Differentiation of slowly growing mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol. 1992;30:1815-1822.
46. Brunello F, Ligozzi M, Cristelli E, et al. Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp 65 gene. J Clin Microbiol. 2001;39:2799-2806.
47. Primm TP, Lucero CA, Falkinham JO III. Health impacts of environmental mycobacteria. Clin Microbiol Rev. 2004;17:98-106.